Search - tctmd.com

Displaying 321 - 340 of 1033

Sort: Relevancy | Date

Presentation TCT 2019

Case Introduction: DAPT Dilemma After a Complex PCI in a High Bleeding Risk Patient

Presenter: Amit Vora

September 26, 2019

Presentation TCT 2019

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in India

Presenter: Upendra Kaul

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in China

Presenter: Run-Lin Gao

September 26, 2019

Presentation TCT 2019

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Presenter: Robert de Winter

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Presenter: Sripal Bangalore

September 26, 2019

Presentation TCT 2019

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Presenter: Greg Kaluza

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Yael L. Maxwell

August 31, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

Advertisement

Case Introduction: DAPT Dilemma After a Complex PCI in a High Bleeding Risk Patient

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Primer on Metallic Stents Developed in India

Primer on Metallic Stents Developed in China

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Polymer-Free DES: Lessons Learned From Recent Trials

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

What I Am Most Looking Forward to at TCT 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content